COMPANY:

Proscia

"Owkin...and Proscia®...have announced a strategic partnership to streamline MSI testing for patients with colorectal cancer (CRC), the second most deadly cancer worldwide. As a first step in the collaboration, the companies will integrate Owkin’s MSIntuit CRC v2 with Proscia’s Concentriq software platform for studying its impact, and make it available as part of Proscia’s precision medicine AI portfolio to enable laboratories to keep pace with demand for MSI screening."

"Proscia...partnered with Nucleai, a leading spatial AI biomarker company that maps protein expression and cellular interactions within tissue samples to predict therapeutic outcomes. At the center of the collaboration, the companies will integrate Nucleai’s predictive biomarker solutions into Proscia’s Concentriq® software platform and make them available as part of Proscia’s precision medicine AI portfolio to better inform patient care."

"CellNetix Pathology & Laboratories...is innovating its practice with digital pathology to advance its mission of excellence. In doing so, it will provide faster, more confident results and lay the foundation for artificial intelligence (AI)-driven pathology. CellNetix is working with Proscia, a leading provider of digital and computational pathology solutions."

"DoMore Diagnostics...and Proscia...have partnered to help pathologists predict outcomes for colorectal cancer (CRC) patients. The collaboration paves the way for integrating artificial intelligence (AI)-powered clinical decision support into routine pathology workflows, unlocking new insights that can guide increasingly precise treatment decisions and ensure patients receive optimal care...The partnership paves the way for delivering an integrated solution that combines DoMore Diagnostics’ CE-IVDD marked Histotype Px^® Colorectal* digital biomarker with Proscia’s CE-IVDR marked Concentriq^® Dx** enterprise pathology platform."

"HNL Lab Medicine...pleased to announce an investment in a new digital pathology initiative. HNL Lab Medicine has selected solutions from Proscia...and Leica Biosystems...to establish an advanced digital pathology practice. This investment will enhance the lab’s diagnostic capabilities, improve efficiency, and ultimately provide better patient care."

"Mindpeak...and Proscia...have announced a partnership to broaden access to improved diagnosis for cancer patients. Through the collaboration, the companies lay the foundation for delivering tightly integrated AI-powered workflows that enable pathologists to provide more efficient, informed, and reproducible clinical decisions."

"Proscia...announced that Virscio...has deployed Concentriq® for Research. The contract research organization (CRO) is leveraging Proscia’s flagship software platform to provide faster, more informed drug safety insights, helping its sponsors to improve research and development (R&D) efficiency."